These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6377774)

  • 1. [Prospects for using bacteriocins for the prevention and therapy of infections].
    Blinova LP
    Zh Mikrobiol Epidemiol Immunobiol; 1984 May; (5):10-4. PubMed ID: 6377774
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of the bacteriocinogenic factor in different biological systems; recent advances.
    Israil AM
    Arch Roum Pathol Exp Microbiol; 1983; 42(1):31-44. PubMed ID: 6400739
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of sporulating bacteria in treating patients with dysbacteriosis].
    Voĭchishina LG; Chaplinskiĭ VIa; V'iunitskaia VA
    Vrach Delo; 1991 Dec; (12):73-5. PubMed ID: 1792782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug discovery: Leaving no stone unturned.
    Gammon K
    Nature; 2014 May; 509(7498):S10-2. PubMed ID: 24784422
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for antigenic differences among pyocins of Pseudomonas aeruginosa.
    Allen JC; Kelly PC
    Trans Am Clin Climatol Assoc; 1975; 86():51-8. PubMed ID: 52229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Function and structure of bacteriocins and rapidosomes].
    Gariaev PP
    Usp Sovrem Biol; 1970; 70(2):166-81. PubMed ID: 5497762
    [No Abstract]   [Full Text] [Related]  

  • 7. Commercial development and application of type A lantibiotics.
    Wilson-Stanford S; Smith L
    Recent Pat Antiinfect Drug Discov; 2011 May; 6(2):175-85. PubMed ID: 21517737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacteriocins of gram-positive bacteria.
    Tagg JR; Dajani AS; Wannamaker LW
    Bacteriol Rev; 1976 Sep; 40(3):722-56. PubMed ID: 791239
    [No Abstract]   [Full Text] [Related]  

  • 9. Colicin-like bacteriocins as novel therapeutic agents for the treatment of chronic biofilm-mediated infection.
    Brown CL; Smith K; McCaughey L; Walker D
    Biochem Soc Trans; 2012 Dec; 40(6):1549-52. PubMed ID: 23176515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocins: New Potential Therapeutic Candidates in Cancer Therapy.
    Fathizadeh H; Saffari M; Esmaeili D; Moniri R; Kafil HS
    Curr Mol Med; 2021 Apr; 21(3):211-220. PubMed ID: 33109060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental immunological effectiveness and safety of pyoimmunogen vaccine against Pseudomonas aeruginosa infection].
    Stanislavskiĭ ES; Ioo I; Severtsova MK; Mashilova GM; Boltutsiĭ LG
    Zh Mikrobiol Epidemiol Immunobiol; 1982 May; (5):70-5. PubMed ID: 6808791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of Pseudomonas aeruginosa infections with pyocines.
    Williams RJ
    J Med Microbiol; 1976 May; 9(2):153-61. PubMed ID: 819653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between pyocine and temperate phage of Pseudomonas aeruginosa (author's transl)].
    Shionoya H; Homma Y
    Tanpakushitsu Kakusan Koso; 1979 Apr; 24(6):867-70. PubMed ID: 112650
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of bacterial preparations on the survival of irradiated animals].
    Mal'tsev VN; Gutsenko KK; Emchenko NV; Shvachko AG; Ivanov AA
    Radiats Biol Radioecol; 1994; 34(4-5):578-81. PubMed ID: 7951887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial interference and competition.
    Wannamaker LW
    Scand J Infect Dis Suppl; 1980; Suppl 24():82-5. PubMed ID: 7010567
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial interference.
    Brook I
    Crit Rev Microbiol; 1999; 25(3):155-72. PubMed ID: 10524328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study of F-type pyocins of Pseudomonas aeruginosa.
    Kuroda K; Kageyama M
    J Biochem; 1981 Jun; 89(6):1721-36. PubMed ID: 6793563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Characteristic, properties, prospect of application of bacteriocins].
    Balko AB
    Mikrobiol Z; 2012; 74(6):99-106. PubMed ID: 23293833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of the effectiveness of biological antagonist preparations in intestinal infections in children].
    Avanesova AG; Lazareva NA; Ruzaikina NI; D'iakova EI; Kurnosova NA
    Vopr Okhr Materin Det; 1973 Jul; 18(7):39-43. PubMed ID: 4762308
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bificol in the complex treatment of patients with infectious diseases].
    Markova EA; Dvurechenskaia GS; Pospelova VV; Rakhimova NG
    Ter Arkh; 1979; 51(2):99-101. PubMed ID: 371053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.